Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 5.1 EX-5.1
- 8.1 EX-8.1
- 8.2 EX-8.2
- 10.81 EX-10.81
- 10.82 EX-10.82
- 10.83 EX-10.83
- 10.84 EX-10.84
- 10.85 EX-10.85
- 23.1 EX-23.1
- 23.2 EX-23.2
- 23.3 EX-23.3
- 99.1 EX-99.1
- 99.2 EX-99.2
- 99.3 EX-99.3
- 99.4 EX-99.4
- 99.5 EX-99.5
- 99.6 EX-99.6
- 99.7 EX-99.7
- 99.8 EX-99.8
ANIP similar filings
- 26 Apr 13 Registration of securities issued in business combination transactions
- 18 Jan 13 Registration of securities issued in business combination transactions (amended)
- 11 Dec 12 Registration of securities issued in business combination transactions
- 19 Aug 09 Registration of securities issued in business combination transactions (amended)
Filing view
External links
EXHIBIT 99.6
CONSENT OF PERSON ABOUT TO BECOME A DIRECTOR
In accordance with Rule 438 promulgated under the Securities Act of 1933, as amended, the undersigned hereby consents to being named in the Registration Statement on Form S-4 filed by BioSante Pharmaceuticals, Inc. (“BioSante”) with the Securities and Exchange Commission on April 25, 2013, and all supplements and amendments thereto (the “Registration Statement”), as a person about to become a director of BioSante effective upon completion of the merger as described in the Registration Statement.
Dated: April 26, 2013 |
| |
|
| |
|
| |
/s/ Robert Schrepfer |
|
|
Robert Schrepfer |
| |